Thursday, November 14, 2013

Indo-Asian scenario of microbes, infections, antibiotics and resistance - By Dr. A. J. Tamhankar (Research Associate: Sandeep Nerkar)

Tuesday, July 23, 2013

Indo-Asian scenario of microbes, infections, antibiotics and resistance - By Dr. A. J. Tamhankar (Research Associate: Sandeep Nerkar)

Bacteria growing increasingly resistant to drugs......Daily News & Analysis.....When a patient develops resistance towards a drug, he might need stronger antibiotics the next time he gets a bacterial infection, and the side-effects and ... 


Aurora Sinai patient has 'nightmare bacteria' infection..... Milwaukee Journal Sentinel....A patient with an infection caused by a deadly superbug that federal officials ... they infect because the bacteria are highly resistant to antibiotics, ... 


Aurora Sinai patient has 'nightmare bacteria' infection MENAFN.COM.....Those countries where CRE are an issue includeIndia, Greece, Italy, Pakistan and ... they infect because the bacteria are highly resistant to antibiotics, ... 


Medical curriculum must be modernised, says Chennai doctor.....The Hindu.....The Indian medical curriculum must be modernised to provide training in rational antibiotic use and infection control for all medical students, Abdul Ghafur ... 


Socialize Big Pharma! Salon... in India a few years ago. Ricci suffered infections from drug-resistant bacteria that even highly toxic last-resort antibiotics could not treat. 

Extensive use of antibiotics may lead Kolkata to a disaster ...Times of India  

Cluster of two CA-MRSA cases under CHP investigation.... Hong-Kong SAR 

Wednesday, July 10, 2013

Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves








http://www.dovepress.com/articles.php?article_id=13563


Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves




Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) remains one of the most important causes of nosocomial infections worldwide. Since the global spread of MRSA in the 1960s, MRSA strains have evolved with increased pathogenic potential. Notably, some strains are now capable of causing persistent infections not only in hospitalized patients but also in healthy individuals in the community. Furthermore, MRSA is increasingly associated with infections among livestock-associated workers, primarily because of transmission from animals to humans. Moreover, many MRSA strains have gained resistance to most available antibiotics. In this review, we will present current knowledge on MRSA epidemiology and discuss new endeavors being undertaken to understand better the molecular and epidemiological underpinnings of MRSA outbreaks.


Keywords: Staphylococcus aureus, MRSA, nosocomial infection, community-associated infection

Saturday, July 6, 2013

Govt mulling ban on sale of TB drugs in open market

 



BL A protest in Mumbai against the developed countries move to block access to HIV and TB drugs.
TOPICS

Sale of tuberculosis drugs could be prohibited in open market as part of efforts to ensure calibrated and monitored administration of these medicines which would then only be given on daily basis free of cost by government registered outlets to patients.

The Health Ministry is proposing changes in view of irregularity in administration of these drugs to patients and lack of proper monitoring which is hindering efforts to check the disease, sources told PTI.

According to a WHO estimate, India is home to the largest number of TB patients - 2.2 million of the world’s 8.7 million.

Patients are administered TB medicines either through government-run hospitals and clinics free of cost or by private practitioners.

According to the Health Ministry, about 65 per cent of the TB patients avail these drugs under the government’s DOT (Daily Observed Therapy) System while the rest opt for treatment by private practitioners and buy drugs from the chemists based on their prescription.

The latter results in irregularity of treatment which leads to relapse of the ailment as there is lack of proper monitoring, the sources said citing experts.
To address this, the government is planning to prohibit sale of drugs in open market.

Under the new initiative, patients going to private practitioners for treatment will get medicines free of cost from chemists but only after the doctor informs them through a dedicated call centre to be set up by the government.

The changes are being brought to ensure that all TB patients are administered the drugs on daily basis instead of intermittently as at present.
Recently, Health Minister Gulam Nabi Azad had expressed concern on the issue saying that the irregular regime is leading to growing resistance to anti-TB drugs.

The Health Ministry officials recently had held a meeting with WHO and other experts who had emphasised on changing intermittent dosage system to daily regime.

During the meeting, it was informed that many other countries including Brazil, China, which were following the intermittent dosage system, have now turned to daily regime.
 

Monday, May 13, 2013

Indo-Asian scenario of microbes, infections, antibiotics and resistance - By Dr. A. J. Tamhankar (Research Associate: Sandeep Nerkar)



Monday, April 1, 2013

Drug alert system by CDSCO picks up momentum

Joseph Alexander, New Delhi

The drug alert system, launched by the Central Drugs Standard Control Organisation (CDSCO) to inform the public about the drugs, devices and cosmetics found substandard or spurious during the tests, has picked up momentum with different drug testing laboratories reporting 12 cases during January.

After the system was launched in November with three cases that came from the Central Drug Testing Lab in Chennai alone, the number of such cases went to seven with more labs sending in reports to the DCGI office in December. The alert system also has prompted the companies to recall the batches of drugs found substandard.

CDL, Kolkota has reported four cases while regional central drug testing lab of Guwahati and CDTL, Chennai reported three cases each in January. Regional lab at Chandigarh and CDTL in Mumbai also sent reports about one each cases.

Brexic DT (piroxicam dispersible tablets 20 mg) having batch no. WBI-1207 and manufactured by Wockhardt Ltd was among the cases reported. Cloxacid- D 500 capsules (bath no WGS 1204) by G S Pharmaceuticals was sent by Arunachal Pradesh Drugs Control Department to RDTL Guwahati and was  found substandard in the assay test in another instance.

Adrenaline injection IP (b.no – AD1N1L) by Arco Life Sciences of Nagpur,  telmisartan and hydrochlorothiazide tablets USP (Arbitel-H) having batch number of ARHD0029 and manufactured by Micro Labs of Baddhi,  diclofenac sodium tablets IP 50 mg (Batch No. DF110) by Eurokem Laboratories (P) Ltd of Alathur in Tamil Nadu, and Spasdor tablets (dicyclomine HCL and mafenamic acid tablets) having batch No. JKT-12107 and manufactured by Japsi Chem Pharmaceuticals of Solan were also among those reported as substandard.  Another drug, Pyricure-650 (paracetamol tablets) with batch No. JLT-1221, manufactured by Japsi was also found substandard in the test done by Chennai lab.

Spinz talcum powder (batch no L3) by Cavincare Pvt Ltd failed the test for microbial limit while Oroceph-500 capsule (batch no OC5-7033) by Lark Laboratories was found to be having no uniformity with that of net content. Lupisera-D tablets (b.no. 005 E1ABY) by Akums Drugs and Pharmaceuticals Ltd, Carvas 3.125 (carvedilol tablets IP) with batch no of E20053 manufactured by Medley Pharmaceuticals and Ondasentron tablets (B.No 1103) by Deepin Pharmaceuticals were also included in the alert list.

Sunday, January 6, 2013

Indo-Asian scenario of microbes, infections, antibiotics and resistance - By Dr. A. J. Tamhankar (Research Associate: Sandeep Nerkar)

Antibiotic against cough loses potency, thanks to random use-Times of India...NEW DELHI: One of India's most commonly used antibiotic against cough has become ... "Most bacteria will ultimately become resistant to antibiotics if taken ... 
Is the antibiotic against cough actually bad for us? India.Com Health... antibiotic amoxicillin, regularly prescribed for bacterial infections of the chest, ... In India, it's usually used to treat cough and lower respiratory ...
Bacteria causing UTI infections becoming immune to drugs :Daily Pioneer....E. coli bacteria, a major cause for urinary tract infections (UTI), is increasingly becoming resistant to the most prescribed antimicrobial, ...

Hong Kong SAR – ’MRSA levelling off’; seems like more MRSA in society than in the hospitals – South China Morning Post
India –  a study on amoxicillin against non-pneumonic RTI, published in Lancet Infectious Diseases, is also reviewed in Times of India